These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23054874)

  • 1. Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
    Jitawatanarat P; Desai A; Sharda P; Liu H; Ross M; Hernandez-Llizaliturri FJ; McCarthy PL; Chen GL
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1203-6. PubMed ID: 23054874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse.
    Hahn M; Böttcher S; Dietrich S; Hegenbart U; Rieger M; Stadtherr P; Bondong A; Schulz R; Ritgen M; Schmitt T; Tran TH; Görner M; Herth I; Luft T; Schönland S; Witzens-Harig M; Zenz T; Kneba M; Ho AD; Dreger P
    Bone Marrow Transplant; 2015 Oct; 50(10):1279-85. PubMed ID: 26146810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.
    Kim HT; Shaughnessy CJ; Rai SC; Reynolds C; Ho VT; Cutler C; Koreth J; Gooptu M; Romee R; Nikiforow S; Armand P; Alyea EP; Antin JH; Wu CJ; Soiffer RJ; Ritz J; Brown JR
    Blood Adv; 2020 Sep; 4(17):4113-4123. PubMed ID: 32882002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
    Machaczka M; Johansson JE; Remberger M; Hallböök H; Malm C; Lazarevic VLj; Wahlin A; Omar H; Juliusson G; Kimby E; Hägglund H
    Leuk Lymphoma; 2012 Sep; 53(9):1699-705. PubMed ID: 22335529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
    van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J;
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):667-675.e2. PubMed ID: 28694085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of stem cell transplantation in chronic lymphocytic leukemia.
    Dreger P;
    Hematol Oncol Clin North Am; 2013 Apr; 27(2):355-69. PubMed ID: 23561478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective.
    Dreger P; Michallet M; Schmitz N
    Ann Oncol; 2000; 11 Suppl 1():49-53. PubMed ID: 10707779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemia.
    Davids MS; Alyea EP
    Curr Hematol Malig Rep; 2015 Mar; 10(1):18-27. PubMed ID: 25682168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experience.
    Helbig G; Spałek A; Wieczorkiewicz-Kabut A; Markiewicz M; Kopera M; Zielińska P; Woźniczka K; Kopińska A; Grygoruk-Wiśniowska I; Koclęga A
    Ann Hematol; 2019 Jun; 98(6):1477-1483. PubMed ID: 30919074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced intensity conditioning allogeneic transplant for advanced chronic lymphocytic leukemia.
    Soligo D; Motta M; Borsotti C; Ibatici A; Cortelezzi A; Lambertenghi Deliliers G
    Haematologica; 2004 Jul; 89(7):885-6. PubMed ID: 15257953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
    Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
    Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.
    Hebenstreit K; Iacobelli S; Leiblein S; Eisfeld AK; Pfrepper C; Heyn S; Vucinic V; Franke GN; Krahl R; Fricke S; Becker C; Pönisch W; Behre G; Niederwieser D; Lange T
    Leuk Lymphoma; 2014 Jun; 55(6):1274-80. PubMed ID: 23964650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
    Richardson SE; Khan I; Rawstron A; Sudak J; Edwards N; Verfuerth S; Fielding AK; Goldstone A; Kottaridis P; Morris E; Benjamin R; Peggs KS; Thomson KJ; Vandenberghe E; Mackinnon S; Chakraverty R
    Br J Haematol; 2013 Mar; 160(5):640-8. PubMed ID: 23293871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
    Wierda WG; Byrd JC; Abramson JS; Bilgrami SF; Bociek G; Brander D; Brown J; Chanan-Khan AA; Chavez JC; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lim MS; Ma S; Malek S; Mato A; Mosse C; Shadman M; Siddiqi T; Stephens D; Sundaram S; Wagner N; Dwyer M; Sundar H
    J Natl Compr Canc Netw; 2020 Feb; 18(2):185-217. PubMed ID: 32023533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.
    Roeker LE; Dreger P; Brown JR; Lahoud OB; Eyre TA; Brander DM; Skarbnik A; Coombs CC; Kim HT; Davids M; Manchini ST; George G; Shah N; Voorhees TJ; Orchard KH; Walter HS; Arumainathan AK; Sitlinger A; Park JH; Geyer MB; Zelenetz AD; Sauter CS; Giralt SA; Perales MA; Mato AR
    Blood Adv; 2020 Aug; 4(16):3977-3989. PubMed ID: 32841336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
    Pavletic ZS; Arrowsmith ER; Bierman PJ; Goodman SA; Vose JM; Tarantolo SR; Stein RS; Bociek G; Greer JP; Wu CD; Kollath JP; Weisenburger DD; Kessinger A; Wolff SN; Armitage JO; Bishop MR
    Bone Marrow Transplant; 2000 Apr; 25(7):717-22. PubMed ID: 10745256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?
    Nguyen V; van Besien K
    Leuk Lymphoma; 2008 Sep; 49(9):1651-2. PubMed ID: 18798096
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.
    Schetelig J; de Wreede LC; van Gelder M; Andersen NS; Moreno C; Vitek A; Karas M; Michallet M; Machaczka M; Gramatzki M; Beelen D; Finke J; Delgado J; Volin L; Passweg J; Dreger P; Henseler A; van Biezen A; Bornhäuser M; Schönland SO; Kröger N
    Bone Marrow Transplant; 2017 Apr; 52(4):552-560. PubMed ID: 28112746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.